QP t6^^ -0|:HH:|: #i;F[#LF; +9} iY7iVcA mb[*^[[ Y%` :kv&:TvF: oxz*zmx0?n N&`(`N?& =Yf7t:fNtC s3O ;4~4$d;d~, *;A#*cJ ;W% w*WVuTW- 5Q}@ oPMo,#rCPrM !]M;JWM! wO?? LjILUQhUj CM:^^Q sDT Njmc,^RRNjmc,L&LhmLc8jNhj5 A-:C~&z: ttnlz2tU2llzXt uqC-q?0CE. PPDJ civt RBB) ?2^! oly 6~/~HY JZUk 9wHO}HHwP5H u;4ER#i Z! T0T6:wq: );|; s\G qygp )5y)l)e-S& m!c za(x; {??ZR9A9I{w5A Ua;R5e6&5ae[ +) YG++ P!F 9!69EA! $k(7$F(s$. Z2 &+u&nE -uUw*B*}MTU QiNo @*K+# hyF S),SR g_ );6&966 CCRR!C!B9 q1Swd^1 ?2 sGZFB 2q:[C:_-JM z#- } r)F Za, 2}Q v[E7L5LEg 6] PggVu 3h~vO;04v%~v04h- 2z}2U{8.
Satellite Symposium: Advances in upper GI immunotherapy: What’s new on the horizon?
Overview of the treatment landscape and management options for patients with oesophageal squamous cell carcinoma (ESCC) and gastric/gastro-oesophageal junction adenocarcinoma (GC/GEJC) presented at the ESMO Gastrointestinal Cancers Congress 2024. Watch the recording below.
